162 related articles for article (PubMed ID: 22528394)
1. Knockdown of NYGGF4 increases glucose transport in C2C12 mice skeletal myocytes by activation IRS-1/PI3K/AKT insulin pathway.
Zeng XQ; Zhang CM; Tong ML; Chi X; Li XL; Ji CB; Zhang R; Guo XR
J Bioenerg Biomembr; 2012 Jun; 44(3):351-5. PubMed ID: 22528394
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway.
Wu WL; Gan WH; Tong ML; Li XL; Dai JZ; Zhang CM; Guo XR
Mol Genet Metab; 2011 Mar; 102(3):374-7. PubMed ID: 21185755
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt.
Zhang CM; Chen XH; Wang B; Liu F; Chi X; Tong ML; Ni YH; Chen RH; Guo XR
Acta Pharmacol Sin; 2009 Jan; 30(1):120-4. PubMed ID: 19079291
[TBL] [Abstract][Full Text] [Related]
4. NYGGF4 (PID1) effects on insulin resistance are reversed by metformin in 3T3-L1 adipocytes.
Qiu J; Wang YM; Shi CM; Yue HN; Qin ZY; Zhu GZ; Cao XG; Ji CB; Cui Y; Guo XR
J Bioenerg Biomembr; 2012 Dec; 44(6):665-71. PubMed ID: 22968630
[TBL] [Abstract][Full Text] [Related]
5. α-Lipoic acid protects 3T3-L1 adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance through increasing phosphorylation of IRS-1 and Akt.
Wang YM; Lin XF; Shi CM; Lu L; Qin ZY; Zhu GZ; Cao XG; Ji CB; Qiu J; Guo XR
J Bioenerg Biomembr; 2012 Jun; 44(3):357-63. PubMed ID: 22528396
[TBL] [Abstract][Full Text] [Related]
6. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TFAM protects 3T3-L1 adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance and mitochondrial dysfunction.
Shi CM; Xu GF; Yang L; Fu ZY; Chen L; Fu HL; Shen YH; Zhu L; Ji CB; Guo XR
Cell Biochem Biophys; 2013 Jul; 66(3):489-97. PubMed ID: 23274913
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of LYRM1 inhibits glucose transport in rat skeletal muscles via attenuated phosphorylation of PI3K (p85) and Akt.
Kou C; Cao X; Qin D; Ji C; Zhu J; Zhang C; Zhu C; Gao C; Chen R; Guo X; Zhang M
Mol Cell Biochem; 2011 Feb; 348(1-2):149-54. PubMed ID: 21072680
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits glucose uptake activity and GLUT4 translocation through suppression of the IR/IRS-1/Akt signaling in C2C12 myotubes.
Li W; Liang X; Zeng Z; Yu K; Zhan S; Su Q; Yan Y; Mansai H; Qiao W; Yang Q; Qi Z; Huang Z
Biomed Pharmacother; 2016 Oct; 83():194-200. PubMed ID: 27470565
[TBL] [Abstract][Full Text] [Related]
10. Hydroxylamine enhances glucose uptake in C2C12 skeletal muscle cells through the activation of insulin receptor substrate 1.
Kimura T; Kato E; Machikawa T; Kimura S; Katayama S; Kawabata J
Biochem Biophys Res Commun; 2014 Feb; 445(1):6-9. PubMed ID: 24462868
[TBL] [Abstract][Full Text] [Related]
11. Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition.
Li HB; Yang YR; Mo ZJ; Ding Y; Jiang WJ
Braz J Med Biol Res; 2015 May; 48(5):440-6. PubMed ID: 25760026
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-like factor 14 increases insulin sensitivity through activation of PI3K/Akt signal pathway.
Yang M; Ren Y; Lin Z; Tang C; Jia Y; Lai Y; Zhou T; Wu S; Liu H; Yang G; Li L
Cell Signal; 2015 Nov; 27(11):2201-8. PubMed ID: 26226221
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of NYGGF4 (PID1) rescues insulin resistance and mitochondrial dysfunction induced by FCCP in 3T3-L1 adipocytes.
Shi CM; Wang YM; Zhang CM; Qiu J; Shen YH; Zhu JG; Chen L; Xu GF; Zhao YP; Ji CB; Guo XR
Mitochondrion; 2012 Nov; 12(6):600-6. PubMed ID: 23085536
[TBL] [Abstract][Full Text] [Related]
14. Caulerpa lentillifera extract ameliorates insulin resistance and regulates glucose metabolism in C57BL/KsJ-db/db mice via PI3K/AKT signaling pathway in myocytes.
Sharma BR; Kim HJ; Rhyu DY
J Transl Med; 2015 Feb; 13():62. PubMed ID: 25889508
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK/IκBα pathway.
Zhu R; Zheng J; Chen L; Gu B; Huang S
Int J Mol Med; 2016 Jun; 37(6):1697-705. PubMed ID: 27082050
[TBL] [Abstract][Full Text] [Related]
16. Myostatin inhibits glucose uptake via suppression of insulin-dependent and -independent signaling pathways in myoblasts.
Liu XH; Bauman WA; Cardozo CP
Physiol Rep; 2018 Sep; 6(17):e13837. PubMed ID: 30252210
[TBL] [Abstract][Full Text] [Related]
17. Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.
Chao H; Li H; Grande R; Lira V; Yan Z; Harris TE; Li C
Mol Endocrinol; 2015 Jun; 29(6):831-41. PubMed ID: 25875045
[TBL] [Abstract][Full Text] [Related]
18. Overactivation of NF-κB impairs insulin sensitivity and mediates palmitate-induced insulin resistance in C2C12 skeletal muscle cells.
Zhang J; Wu W; Li D; Guo Y; Ding H
Endocrine; 2010 Feb; 37(1):157-66. PubMed ID: 20963565
[TBL] [Abstract][Full Text] [Related]
19. MiR-222-3p suppresses C2C12 myoblast proliferation and differentiation via the inhibition of IRS-1/PI3K/Akt pathway.
Wei X; Wang J; Sun Y; Zhao T; Luo X; Lu J; Hou W; Yu X; Xue L; Yan Y; Wang H
J Cell Biochem; 2023 Sep; 124(9):1379-1390. PubMed ID: 37565526
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway.
Sasaki-Suzuki N; Arai K; Ogata T; Kasahara K; Sakoda H; Chida K; Asano T; Pessin JE; Hakuno F; Takahashi S
J Biol Chem; 2009 Mar; 284(10):6061-70. PubMed ID: 19122000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
